DiaSorin (FTSE Mid Cap:DIA) is proud to announce the launch of its novel 1,25 Dihydroxyvitamin D assay for the quantitative determination of 1,25 Dihydroxyvitamin D levels in human serum and plasma, available on the LIAISON XL analyzer for the market outside the US only.

 

DiaSorin is pleased to announce it has signed a 3 year extension of its master agreement, through the end of 2018, with Laboratory Corporation of America Holdings

Dialog

New communication area.
To download technical Assays information